ArticleJournal of hepatocellular carcinoma2025
Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.
Ching-Tso Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.